Cellectar BioSciences Inc. (CLRB)

1.89
0.01 0.53
NASDAQ : Health Technology
Prev Close 1.90
Open 1.93
Day Low/High 1.82 / 1.94
52 Wk Low/High 1.22 / 14.00
Volume 47.73K
Avg Volume 53.20K
Exchange NASDAQ
Shares Outstanding 4.76M
Market Cap 9.04M
EPS -10.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Cellectar Granted Seminal U.S. Patent For Phospholipid-Ether Analogs As Cancer-Targeting Drug Vehicles

Cellectar Granted Seminal U.S. Patent For Phospholipid-Ether Analogs As Cancer-Targeting Drug Vehicles

Covers composition of matter and method of use for proprietary PDCs™ in combination with anti-cancer agents

Cellectar Reports 2017 Financial Results And Provides A Corporate Update

Cellectar Reports 2017 Financial Results And Provides A Corporate Update

Conference call to be held tomorrow at 8:30 a.m. Eastern time

Cellectar Announces Expansion Of Relapsed/Refractory Multiple Myeloma Cohort In Phase 2 Trial Of CLR 131

Cellectar Announces Expansion Of Relapsed/Refractory Multiple Myeloma Cohort In Phase 2 Trial Of CLR 131

Multiple myeloma cohort exceeded pre-specified criteria for clinically meaningful benefit